Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Engcan77on Sep 29, 2022 10:02am
127 Views
Post# 34994606

RE:RE:RE:total ballpark deal value

RE:RE:RE:total ballpark deal value Biorun. You are throwing a lot of numbers out there without knowing what was on the table. Was the upfront payment either 1 million with more royalties or 2 million with a smaller or larger royalty revenue. Or are we talking between 1 million to 50 million difference for upfront. Only they know.  Also will the royalty payments start coming in next month, next year or longer.
All i know is that a bird in the hand is worth 2 in the bush, as the saying goes. Use the larger upfront payment (if it was anything sufficient) to push along the other pipelines along at a faster rate. Even use the money to bring in a decent CEO. 
You don't seem to have much confidence in management, if you think they will burn through the cash and end up at square one. 

I cannot believe you actually said that some people are looking at a take your money and run scenario, when the majority have been here for multiple years. You can't even go there.
<< Previous
Bullboard Posts
Next >>